VAERS reports by lot

Sanofi Pasteur DTaP/Tdap lot U5882AA: VAERS reports

24 VAERS reports list lot U5882AA as a Sanofi Pasteur DTaP/Tdap vaccine, received between 2018-02-15 and 2020-04-21. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
24
Reports
0%
Marked serious
0
With a death outcome
13
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction2034%
General / Systemic (non-local)1220%
Allergic / Anaphylactic58%
Musculoskeletal58%
Cardiac / Cardiovascular47%
Gastrointestinal47%
Dermatological (non-injection-site)47%
Neurological23%
Respiratory23%
Psychiatric / Neuropsychiatric12%

Where reports came from

U.S. state of the reporter, where given (top 12).

North Carolina5
Michigan2
Pennsylvania2
Arizona2
California2
Minnesota2
Iowa1
Hawaii1
North Dakota1
Connecticut1
Texas1
New York1

Reports by month received

2018-021
2018-032
2018-051
2018-065
2018-092
2018-111
2018-121
2019-012
2019-051
2019-061
2019-081
2020-032
2020-044

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.